Helping you to get closer to zero human and economic consequence of wounds.
Don’t forget to follow @smithnephew on Twitter for regular updates on Education & Evidence. For detailed product information, including indications for use, contraindications, precautions and warnings, please consult the product’s applicable Instructions for Use (IFU) prior to use.
*As demonstrated in vivo/vitro.
i) 164 patients with lower extremity ulcers for more than 4 weeks. 104 with VLUs (2-36cm2), 60 with DFUs (0.5-10cm2). 63.4% male and 36.6% female, with a mean age of 61.5 years. ii) Wound area: p<0.001 (VLUs: p=0.007, DFUs: p=0.031) iii) Wound depth: p<0.014 iv) Wound volume: p<0.013 v) Wound closure: p=0.002 vi) Overall patient satisfaction: p=0.006